HbA1c might be falsely elevated in patients with acute stage of COVID-19 as a result of disrupted hemoglobin kinetics caused by SARS-CoV-2 and/or HPLC detection of densely glycosylated S-proteins on the SARS-CoV-2 virion surface. This evidence concerns the gene PROS1 and COVID-19.